skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 81,606  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Database: Springer Nature OA/Free Journals remove subject: Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Material Type:
Article 		Add to My Research

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.575-586 [Peer Reviewed Journal]

The Author(s) 2016 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-4085-4 ;PMID: 28008555 ;CODEN: BCTRD6

Full text available

Citations Cited by
2
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer
Material Type:
Article 		Add to My Research

Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer

Breast cancer (Tokyo, Japan), 2024-05, Vol.31 (3), p.485-495 [Peer Reviewed Journal]

The Author(s) 2024 ;2024. The Author(s). ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-024-01560-y ;PMID: 38507145

Digital Resources/Online E-Resources

Citations Cited by
3
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis
Material Type:
Article 		Add to My Research

Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis

BMC cancer, 2016-07, Vol.16 (1), p.375-375, Article 375 [Peer Reviewed Journal]

COPYRIGHT 2016 BioMed Central Ltd. ;COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;The Author(s). 2016 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-016-2414-y ;PMID: 27377827

Full text available

Citations Cited by
4
Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinations
Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinations
Material Type:
Article 		Add to My Research

Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinations

Journal of cancer research and clinical oncology, 2022-02, Vol.148 (2), p.441-447 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-021-03623-5 ;PMID: 33991247

Full text available

Citations Cited by
5
Cytoplasmic DDX3 as prognosticator in male breast cancer
Cytoplasmic DDX3 as prognosticator in male breast cancer
Material Type:
Article 		Add to My Research

Cytoplasmic DDX3 as prognosticator in male breast cancer

Virchows Archiv : an international journal of pathology, 2021-10, Vol.479 (4), p.647-655 [Peer Reviewed Journal]

The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0945-6317 ;EISSN: 1432-2307 ;DOI: 10.1007/s00428-021-03107-4 ;PMID: 33974127

Full text available

Citations Cited by
6
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Material Type:
Article 		Add to My Research

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Breast cancer research : BCR, 2016-02, Vol.18 (1), p.15-15, Article 15 [Peer Reviewed Journal]

COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;Silvestri et al. 2016 ;ISSN: 1465-542X ;ISSN: 1465-5411 ;EISSN: 1465-542X ;DOI: 10.1186/s13058-016-0671-y ;PMID: 26857456

Full text available

Citations Cited by
7
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
Material Type:
Article 		Add to My Research

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement

Breast cancer research and treatment, 2018-05, Vol.169 (1), p.33-42 [Peer Reviewed Journal]

The Author(s) 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4669-2 ;PMID: 29349710

Full text available

Citations Cited by
8
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers
Material Type:
Article 		Add to My Research

Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers

Breast cancer research : BCR, 2018-04, Vol.20 (1), p.28-28, Article 28 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s). 2018 ;ISSN: 1465-542X ;ISSN: 1465-5411 ;EISSN: 1465-542X ;DOI: 10.1186/s13058-018-0951-9 ;PMID: 29665859

Full text available

Citations Cited by
9
Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series
Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series
Material Type:
Article 		Add to My Research

Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series

Breast cancer research : BCR, 2013-01, Vol.15 (5), p.R84-R84, Article R84 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;Copyright © 2013 McCormack et al.; licensee BioMed Central Ltd. 2013 McCormack et al.; licensee BioMed Central Ltd. ;ISSN: 1465-542X ;ISSN: 1465-5411 ;EISSN: 1465-542X ;DOI: 10.1186/bcr3478 ;PMID: 24041225

Full text available

Citations Cited by
10
Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer
Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer
Material Type:
Article 		Add to My Research

Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer

Scientific reports, 2022-01, Vol.12 (1), p.220-220, Article 220 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-04342-0 ;PMID: 34997151

Full text available

Citations Cited by
11
Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer
Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer
Material Type:
Article 		Add to My Research

Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer

Journal of cancer research and clinical oncology, 2018-02, Vol.144 (2), p.337-341 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany 2017 ;Journal of Cancer Research and Clinical Oncology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-017-2539-7 ;PMID: 29098396

Full text available

Citations Cited by
12
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
Material Type:
Article 		Add to My Research

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

BMC cancer, 2017-09, Vol.17 (1), p.620-620, Article 620 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3631-8 ;PMID: 28874143

Full text available

Citations Cited by
13
Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study
Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study
Material Type:
Article 		Add to My Research

Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study

Journal of cancer research and clinical oncology, 2021-08, Vol.147 (8), p.2447-2458 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 ;The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-021-03525-6 ;PMID: 33517468

Full text available

Citations Cited by
14
Elastosis in ERα-positive male breast cancer
Elastosis in ERα-positive male breast cancer
Material Type:
Article 		Add to My Research

Elastosis in ERα-positive male breast cancer

Virchows Archiv : an international journal of pathology, 2021-02, Vol.478 (2), p.257-263 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0945-6317 ;EISSN: 1432-2307 ;DOI: 10.1007/s00428-020-02920-7 ;PMID: 32929565

Full text available

Citations Cited by
15
Identification of differentially expressed microRNAs in human male breast cancer
Identification of differentially expressed microRNAs in human male breast cancer
Material Type:
Article 		Add to My Research

Identification of differentially expressed microRNAs in human male breast cancer

BMC cancer, 2010-03, Vol.10 (1), p.109-109, Article 109 [Peer Reviewed Journal]

COPYRIGHT 2010 BioMed Central Ltd. ;COPYRIGHT 2010 BioMed Central Ltd. ;2010 Lehmann et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2010 Lehmann et al; licensee BioMed Central Ltd. 2010 Lehmann et al; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-10-109 ;PMID: 20331864

Full text available

Citations Cited by
16
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
Material Type:
Article 		Add to My Research

Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker

Breast cancer research : BCR, 2012-02, Vol.14 (1), p.R31-R31, Article R31 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;Copyright ©2012 Johansson et al.; licensee BioMed Central Ltd. 2012 Johansson et al.; licensee BioMed Central Ltd. ;ISSN: 1465-542X ;ISSN: 1465-5411 ;EISSN: 1465-542X ;DOI: 10.1186/bcr3116 ;PMID: 22333393

Full text available

Citations Cited by
17
A comparison of tumour size measurements with palpation, ultrasound and mammography in male breast cancer: first results of the prospective register study
A comparison of tumour size measurements with palpation, ultrasound and mammography in male breast cancer: first results of the prospective register study
Material Type:
Article 		Add to My Research

A comparison of tumour size measurements with palpation, ultrasound and mammography in male breast cancer: first results of the prospective register study

Journal of cancer research and clinical oncology, 2018-02, Vol.144 (2), p.381-387 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2017 ;Journal of Cancer Research and Clinical Oncology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-017-2554-8 ;PMID: 29204896

Full text available

Citations Cited by
18
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
Material Type:
Article 		Add to My Research

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Breast cancer research : BCR, 2018-08, Vol.20 (1), p.82-82, Article 82 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1465-542X ;ISSN: 1465-5411 ;EISSN: 1465-542X ;DOI: 10.1186/s13058-018-1014-y ;PMID: 30071865

Full text available

Citations Cited by
19
Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis
Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis
Material Type:
Article 		Add to My Research

Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis

BMC cancer, 2017-09, Vol.17 (1), p.659-659, Article 659 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3640-7 ;PMID: 28946846

Full text available

Citations Cited by
20
Prognostic models in male breast cancer
Prognostic models in male breast cancer
Material Type:
Article 		Add to My Research

Prognostic models in male breast cancer

Breast cancer research and treatment, 2016-11, Vol.160 (2), p.339-346 [Peer Reviewed Journal]

The Author(s) 2016 ;COPYRIGHT 2016 Springer ;Springer Science+Business Media New York 2016 ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-3991-9 ;PMID: 27671991 ;CODEN: BCTRD6

Full text available

Citations Cited by

Results 1 - 20 of 81,606  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1976  (41)
  2. 1976 To 1987  (187)
  3. 1988 To 1999  (991)
  4. 2000 To 2012  (17,900)
  5. After 2012  (62,491)
  6. More options open sub menu

Resource Type 

  1. Articles  (81,601)
  2. Book Chapters  (5)
  3. More options open sub menu

Subject 

  1. Humans  (81,554)
  2. Male  (81,551)
  3. Science & Technology  (76,423)
  4. Female  (75,799)
  5. Middle Aged  (69,134)
  6. Life Sciences & Biomedicine  (67,256)
  7. Adult  (46,773)
  8. Aged, 80 And Over  (30,909)
  9. Risk Factors  (19,193)
  10. Young Adult  (18,077)
  11. Care And Treatment  (16,742)
  12. Health Aspects  (16,538)
  13. Medicine  (15,478)
  14. Retrospective Studies  (15,212)
  15. Adolescent  (14,290)
  16. Patients  (14,066)
  17. Medicine & Public Health  (13,983)
  18. Oncology  (13,643)
  19. Analysis  (13,639)
  20. More options open sub menu

Language 

  1. English  (81,599)
  2. Japanese  (11,347)
  3. Norwegian  (86)
  4. Portuguese  (33)
  5. Chinese  (21)
  6. French  (8)
  7. Swedish  (4)
  8. German  (2)
  9. BokmÃ¥l, Norwegian  (1)
  10. Russian  (1)
  11. Italian  (1)
  12. Dutch  (1)
  13. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait